| Literature DB >> 32819589 |
Valery M Dembitsky1, Tatyana A Gloriozova2, Vladimir V Poroikov2.
Abstract
This review is dedicated to the comparative analysis of structure-activity relationships for more than 75 natural and synthetic derivatives of adamantane. Some of these compounds, such as amantadine and memantine, are currently used to treat dementia, Alzheimer's and Parkinson's diseases and other neurodegenerative diseases. The data presented show that the pharmacological potential of 1-fluoro- and 1-phosphonic acid adamantane derivatives against Alzheimer's and Parkinson's diseases and other neurodegenerative diseases exceeds those of well-known amantadine and memantine. The information presented in this review highlights the promising directions of studies for biochemists, pharmacologists, medicinal chemists, physiologists, and neurologists, as well as to the pharmaceutical industry. CrownEntities:
Keywords: Amantadine; Anticancer; Memantine; Neurodegenerative diseases; Parkinson’s
Year: 2020 PMID: 32819589 DOI: 10.1016/j.bbrc.2020.06.123
Source DB: PubMed Journal: Biochem Biophys Res Commun ISSN: 0006-291X Impact factor: 3.575